GLP-1–based therapies have transformed our understanding of metabolic health, demonstrating the importance of hormonal regulation, appetite, glucose control, and postprandial physiology.

At the same time, their benefits and limitations have raised interest in alternative and complementary approaches.The success of GLP-1 therapies has also brought new attention to the physiological mechanisms that regulate metabolic health.

This webinar will explore how this perspective is moving us beyond fasting glucose and HbA1c toward a more dynamic understanding of how the body responds to and recovers from each meal. We will introduce the emerging concept of postprandial resilience and explore how Pep2Dia® fits into this evolving perspective.

Join us on October 20th to learn more about :

•    GLP-1

•    postprandial resilience

•    Our solution : Pep2Dia® 

Ingredia is a French company that develops and manufactures high-quality bioactive ingredients for the health and nutrition industry. With a strong focus on science and innovation, Ingredia develops solutions designed to support key health areas, including stress management, joint health, and weight management.